KESTER CAPITAL
Kester Capital is a leading UK mid-market private equity firm. It was established in 2007 as Greenhill Capital Partners Europe (“GCP Europe”), the European private equity arm of Greenhill & Co Inc. Kester Capital is managed by a team of experienced professionals and invests on behalf of a number of blue chip institutional investors. Kester Capital is currently investing its second fund, which was raised in 2013. Kester Capital's target equity investment size is £5 – 25 million.
KESTER CAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2007-01-01
Status:
Active
Contact:
+44 (0)20 3747 5700
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Apache Google Maps COVID-19 Pound Sterling CPanel SSL
Similar Organizations
Arcadia Capital
Arcadia Capital is a mid-market private equity firm.
Capital A Investment Partners
Capital A Investment Partners is a mid market private equity firm.
CapVest Associates
CapVest is a European mid-market private equity firm.
Color Capital
Color Capital invests in things people buy, and how they buy them.
Gresham
Gresham is a leading independent UK mid-market private equity specialist.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-13 | Rephine | Rephine acquired by Kester Capital | N/A |
| 2019-10-23 | You Garden | You Garden acquired by Kester Capital | N/A |
| 2019-08-05 | ComplianceOnline | ComplianceOnline acquired by Kester Capital | N/A |
| 2018-05-30 | Jollyes Retail Group | Jollyes Retail Group acquired by Kester Capital | N/A |
| 2017-09-29 | CETA Insurance | CETA Insurance acquired by Kester Capital | N/A |
| 2012-03-27 | Garrets International | Garrets International acquired by Kester Capital | 17 M GBP |
| 2012-01-01 | AgriBriefing | AgriBriefing acquired by Kester Capital | N/A |
| 2010-01-01 | Chiltern International | Chiltern International acquired by Kester Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-21 | Optibrium | Kester Capital investment in Private Equity Round - Optibrium | N/A |
| 2021-02-08 | Optibrium | Kester Capital investment in Private Equity Round - Optibrium | N/A |
| 2016-06-01 | Avania | Kester Capital investment in Private Equity Round - Avania | N/A |
| 2013-12-10 | Frontier Medical Group | Kester Capital investment in Private Equity Round - Frontier Medical Group | N/A |
| 2011-01-01 | Industry Dynamics | Kester Capital investment in Private Equity Round - Industry Dynamics | N/A |
| 2010-01-01 | Chiltern International | Kester Capital investment in Private Equity Round - Chiltern International | N/A |
| 2008-01-01 | Travel Entertainment Group, Ltd. | Kester Capital investment in Private Equity Round - Travel Entertainment Group, Ltd. | N/A |
| 2007-09-01 | Ironshore Insurance | Kester Capital investment in Private Equity Round - Ironshore Insurance | N/A |
| 2006-12-01 | Xanthus Pharmaceuticals | Kester Capital investment in Series B - Xanthus Pharmaceuticals | 25 M USD |
More informations about "Kester Capital"
Kester Capital
Kester Capital is a London-based firm providing first-time institutional capital to ambitious UK SMEs in healthcare, information and data, and technology sectors.See details»
Kester Capital - Crunchbase Investor Profile
Kester Capital is a leading UK mid-market private equity firm. It was established in 2007 as Greenhill Capital Partners Europe (“GCP Europe”), the European private equity arm of Greenhill & Co Inc. Kester Capital is managed by a team …See details»
Kester Capital - Investments, Portfolio & Company Exits
Jun 21, 2022 Kester Capital 's most notable exits include VIXIO Regulatory Intelligence, Avania, and Chiltern International. ... Avania Avania is a full-service contract research organization …See details»
Bionical Emas sells EMAS Pharma to Kester Capital following …
I’d like to thank everyone at Bionical Emas, EMAS Pharma and Kester Capital for making this happen and I look forward to a very successful 2025.” For further information on Bionical …See details»
Kester Capital investment portfolio - PitchBook
Kester Capital General Information Company Description. Founded in 2006, Kester Capital is a private equity firm based in London, United Kingdom. The firm seeks to invest in companies operating in the healthcare, information & data, …See details»
Kester Capital - Private Equity Investments & Executives
See Kester Capital's 16 investments, 10 executives, and complete investor profile. Founded in 2007, Kester Capital (formerly GCP Capital Partners) is a primary buy-out specialist focused …See details»
All news - Kester Capital
The sale of Atec represents Kester Capital’s fourth consecutive exit over 4x and the eighth consecutive exit over 3x.. August 2024: Kester Capital, a leading UK lower mid-market private equity firm, today announced that following …See details»
Kester Capital | PrivSource
Kester Capital is a UK-based private equity firm specializing in the technology and healthcare sectors. The company partners with ambitious SMEs, providing first-time institutional capital …See details»
KESTER CAPITAL LLP - Companies House
Charges for KESTER CAPITAL LLP (OC323239) More for KESTER CAPITAL LLP (OC323239) Registered office address 14-16 Bruton Place, London, England, W1J 6LX . Company status …See details»
Kester Capital - CB Insights
Nov 8, 2024 About Kester Capital. Kester Capital operates as a private equity firm. It provides investment management and other related services, focused on healthcare, information and …See details»
Kester Capital | Institution Profile | Private Equity International
Kester Capital. News, insights, analysis and data. Kester Capital overview. Founded in 2012, Kester Capital is a London-based investment firm that targets buyout investments across the …See details»
Legal - Kester Capital
The information and services provided on this website are not provided to and may not be used by any person or entity in any jurisdiction where the provision or use thereof would be contrary to …See details»
Kester Capital - Private Equity List
Kester Capital is a primary buy-out specialist, led by entrepreneurial and experienced investors, and focused on UK businesses that require capital in order to unlock their potential. Our target …See details»
Kester Capital backs experienced management team in acquiring …
LONDON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Kester Capital (“Kester”), a leading UK private equity investor focused on the life sciences and technology sectors, alongside a new senior …See details»
Kester Capital Closes Oversubscribed Fund III at
Mar 21, 2024 Kester Capital, a prominent UK lower mid-market private equity firm, celebrates the triumphant conclusion of its latest fundraising endeavor with the closure of Kester Capital …See details»
PE Weekly: More Exits, Consumer Investments Show Positive Signs …
Dec 12, 2024 Kester Capital Acquires Bionical Emas’ EMAS Pharma Division. Following a strategic review, Bionical Emas, a global early access programs and clinical trial supply group, …See details»
Kester Capital - Contacts, Employees, Board Members
Kester Capital has 3 current employee profiles, including Managing Partner and Co-Founder Cameron Crockett. Contacts. Edit Contacts Section. Job Department. Protected Content. …See details»
KESTER CAPITAL III LP - Companies House
Filing history for KESTER CAPITAL III LP (LP023033) More for KESTER CAPITAL III LP (LP023033) Registered office address 24 Grosvenor Street, London, W1K 4QN . Company …See details»
Private equity firm sets out expansion plan for EMAS Pharma
Dec 18, 2024 UK private equity investor Kester Capital has announced it will buy EMAS Pharma, the clinical trial services division of Bionical EMAS. The firm cited the UK trial …See details»
Kester Capital completes carve-out of EMAS Pharma | All news
Kester Capital portfolio company, Factory-CRO Group, a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Boston …See details»